Peringkat dalam Saham
#33756
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
Harga Saham
$0.4523
Terakhir disinkronkan: 2023-03-03
Kapitalisasi Pasar
$6.97M
Perubahan (1 hari)
-19.23%
Perubahan (1 tahun)
0.00%
Perdagangan Lucira Health, Inc. (LHDX)
Harga LHDX dengan kapitalisasi pasar B
Kapitalisasi pasar dari Lucira Health, Inc.(LHDX)
Kapitalisasi Pasar: $6.97M
Per August 2026, Lucira Health, Inc. memiliki kapitalisasi pasar sebesar $6.97M. Ini menjadikan Lucira Health, Inc. sebagai perusahaan 33756th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Lucira Health, Inc. dari 2021 hingga 2026
LHDX dibandingkan dengan 5 teratas stocks paling populer
| Harga LHDX |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.452T
|
+78,259,697.47%
|
|
|
|
|
$4.490T
|
+64,452,686.87%
|
|
|
|
|
$4.162T
|
+59,749,906.09%
|
|
|
|
|
$3.676T
|
+52,772,606.31%
|
|
|
|
|
$2.833T
|
+40,667,310.32%
|
